MedTrace Logo

Percutaneous Cryoablation Versus Partial Nephrectomy for T1b Renal Tumor

NCT04506671 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2021-07-28

No results posted yet for this study

Summary

The aim of our study is to assess the long-term oncological and functional outcomes of cryoablation for T1b renal tumors, as well as such important parameters as the patient's quality of life after treatment, and to compare the results with those after partial nephrectomy.

Conditions

  • Renal Tumor

Interventions

PROCEDURE

Renal biopsy

Renal biopsy will be performed prior to the cryoablation on the basis of the center and according to the current protocols

PROCEDURE

Cryoablation

Cryoablation under CT guidance will be performed on the basis of the center and according to the current protocols

PROCEDURE

Partial nephrectomy

Partial nephrectomy will be performed on the basis of the center and according to the current protocols

Sponsors & Collaborators

  • I.M. Sechenov First Moscow State Medical University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-22
Primary Completion
2025-05-22
Completion
2025-06-22

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04506671 on ClinicalTrials.gov